George L. Bakris, MD

home / authors / george-l-bakris-md

Articles

November 15th 2021

Optimizing Outcomes for Patients With CKD and T2DM

Neil B. Minkoff, MD Rajiv Agarwal, MD, MS Eugene Wright Jr., MD George L. Bakris, MD

Steps that need to be taken to address unmet needs and optimize outcomes for patients who have chronic kidney disease and type 2 diabetes.

November 15th 2021

Emerging Therapies for Chronic Kidney Disease

Neil B. Minkoff, MD George L. Bakris, MD Eugene Wright Jr., MD

An overview of therapies in the pipeline, including other nonsteroidal MRAs, that show potential in treating patients who have chronic kidney disease and type 2 diabetes.

November 15th 2021

SGLT2 Inhibitor Use in Chronic Kidney Disease

Neil B. Minkoff, MD Eugene Wright Jr., MD George L. Bakris, MD

A panel of clinicians react to limitations surrounding the use of SGLT2 inhibitors for patients with chronic kidney disease and type 2 diabetes.

November 11th 2021

Non-steroidal MRAs for Chronic Kidney Disease

Neil B. Minkoff, MD George L. Bakris, MD Rajiv Agarwal, MD, MS

What to know in terms of the mechanism of action of non-steroidal MRA finerenone compared with other therapies used to treat patients with chronic kidney disease and type 2 diabetes.

November 4th 2021

The FIDELIO-DKD Trial in Chronic Kidney Disease

Neil B. Minkoff, MD George L. Bakris, MD

George L. Bakris, MD, describes the design and results of the FIDELIO-DKD trial investigating the effect of finerenone on patients with chronic kidney disease.

November 4th 2021

Chronic Kidney Disease: Treatment Landscape

Neil B. Minkoff, MD George L. Bakris, MD Eugene Wright Jr., MD Rajiv Agarwal, MD, MS

Therapies used to help treat patients who have chronic kidney disease and type 2 diabetes.

October 28th 2021

Establishing Care Pathways to Manage CKD and T2DM

Neil B. Minkoff, MD Rajiv Agarwal, MD, MS George L. Bakris, MD Eugene Wright Jr., MD

Considerations for establishing balance for the care of patients with chronic kidney disease among all types of care settings.

October 28th 2021

Early Identification and Management of CKD

Neil B. Minkoff, MD Eugene Wright Jr., MD Rajiv Agarwal, MD, MS George L. Bakris, MD

What better testing strategies and newer quality measures can do to improve patient referrals to nephrologists for earlier intervention of chronic kidney disease.

October 21st 2021

Measures to Improve Chronic Kidney Disease

Neil B. Minkoff, MD George L. Bakris, MD Eugene Wright Jr., MD

Key takeaways from the National Kidney Foundation’s new HEDIS and MIPS quality measures for patients with chronic kidney disease and type 2 diabetes.

October 21st 2021

Care Coordination for Patients With CKD and T2DM

Neil B. Minkoff, MD George L. Bakris, MD Eugene Wright Jr., MD

Various types of health care professionals who may play a role in treating patients with chronic kidney disease, and recommendations to help overcome barriers that impact risk of disease progression and outcomes for patients.

October 14th 2021

Motivating Patients Who Have CKD and T2DM

Neil B. Minkoff, MD George L. Bakris, MD Eugene Wright Jr., MD Rajiv Agarwal, MD, MS

Strategies that can help clinicians establish and work toward goals when treating patients with chronic kidney disease to help control disease and prevent progression.

October 14th 2021

Preventing Progression of Chronic Kidney Disease

Neil B. Minkoff, MD Rajiv Agarwal, MD, MS George L. Bakris, MD Eugene Wright Jr., MD

A panel of clinicians explain why action is needed to help prevent the risk of progression of chronic kidney disease.

October 7th 2021

Clinical and Economic Burden of Chronic Kidney Disease

Neil B. Minkoff, MD Eugene Wright Jr., MD Rajiv Agarwal, MD, MS George L. Bakris, MD

Financial and clinical concerns surrounding the burden of chronic kidney disease progression, as well as social determinants that factor into managing the condition in the community.

October 7th 2021

Counseling Patients About Chronic Kidney Disease

Neil B. Minkoff, MD Rajiv Agarwal, MD, MS Eugene Wright Jr., MD George L. Bakris, MD

Strategies to help clinicians talk with patients about chronic kidney disease staging and what to expect in terms of prognosis.

September 30th 2021

Assessment and Staging of Chronic Kidney Disease

Neil B. Minkoff, MD George L. Bakris, MD Eugene Wright Jr., MD

Diagnostic criteria and special considerations of nephrologists when assessing patient kidney function and diagnosing chronic kidney disease.